Related Experiment Video
Updated: Mar 26, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis
Lidong Zu1,2, Yunjing Xue3, Jinglong Wang3
1Pathology Center, Shanghai General Hospital/Faculty of Basic Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Abstract:
Increasing evidence shows that micro RNAs (miRNAs) play a critical role in tumor development. However, the role of miRNAs in non-small cell lung cancer (NSCLC) metastasis remains largely unknown. Here, we found that miR-124 expression was significantly impaired in NSCLC tissues and associated with its metastasis. In vitro and in vivo experiments indicate that restoring miR-124 expression in NSCLC cells had a marked effect on reducing cell migration, invasion and metastasis. Mechanistic analyses show that Smad4, a cobinding protein in transforming growth factor-β (TGF-β) pathway, was identified as a new target gene of miR-124. Restoring Smad4 expression in miR-124-infected cells could partially rescue miR-124-induced abolition of cell migration and invasion. Notably, upon TGF-β stimulation, phosphorylation of Smad2/3 was modulated by alteration of miR-124 or Smad4 expression, followed by inducing some special transcription of downstream genes including Snail, Slug and ZEB2, all of which may trigger epithelial-mesenchymal transition and be associated with NSCLC metastasis. Moreover, activation of TGF-β pathway may enhance expression of DNMT3a, leading to hypermethylation on miR-124 promoter. Therefore, heavily loss of miR-124 expression further enhances Smad4 level by this feedback loop. Taken together, our data show for the first time that the feedback loop between miR-124 and TGF-β pathway may play a significant role in NSCLC metastasis. Targeting the loop may prove beneficial to prevent metastasis and provide a more effective therapeutic strategy for NSCLC.
Insights
MicroRNAs (miRNAs) are crucial in cancer. This study reveals miR-124 loss promotes non-small cell lung cancer (NSCLC) metastasis by regulating the TGF-β pathway, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are increasingly recognized for their roles in tumorigenesis.
- The specific involvement of miRNAs in non-small cell lung cancer (NSCLC) metastasis is not well understood.
Purpose of the Study:
- To investigate the role of miR-124 in NSCLC metastasis.
- To elucidate the molecular mechanisms underlying miR-124's function in NSCLC progression.
Main Methods:
- Analysis of miR-124 expression in NSCLC tissues.
- In vitro and in vivo experiments to assess the effect of miR-124 restoration on cell migration, invasion, and metastasis.
- Identification and validation of Smad4 as a direct target of miR-124.
- Investigation of the feedback loop involving miR-124, Smad4, and the transforming growth factor-β (TGF-β) pathway.
Main Results:
- miR-124 expression was significantly decreased in NSCLC tissues and correlated with metastasis.
- Restoring miR-124 suppressed NSCLC cell migration, invasion, and metastasis.
- Smad4 was identified as a direct target of miR-124, and its modulation affected cell migration and invasion.
- A feedback loop involving miR-124, Smad4, and TGF-β signaling was identified, influencing epithelial-mesenchymal transition and NSCLC metastasis.
Conclusions:
- The feedback loop between miR-124 and the TGF-β pathway is critical for NSCLC metastasis.
- Targeting this regulatory loop presents a potential therapeutic strategy for preventing NSCLC metastasis.
Related Concept Videos
TGF - β Signaling Pathway
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways

